[go: up one dir, main page]

Baker et al., 2014 - Google Patents

Chronic alcohol self‐administration in monkeys shows long‐term quantity/frequency categorical stability

Baker et al., 2014

View PDF
Document ID
8159886974246875261
Author
Baker E
Farro J
Gonzales S
Helms C
Grant K
Publication year
Publication venue
Alcoholism: Clinical and Experimental Research

External Links

Snippet

Background The current criteria for alcohol use disorders (AUDs) do not include consumption (quantity/frequency) measures of alcohol intake, in part due to the difficulty of these measures in humans. Animal models of ethanol (EtOH) self‐administration have been …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3431—Calculating a health index for the patient, e.g. for risk assessment
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
    • G06F17/30286—Information retrieval; Database structures therefor; File system structures therefor in structured data stores

Similar Documents

Publication Publication Date Title
Baker et al. Chronic alcohol self‐administration in monkeys shows long‐term quantity/frequency categorical stability
Farhat et al. Pharmacological and behavioral treatment for trichotillomania: An updated systematic review with meta‐analysis
Johnson et al. Hypoglycaemia, fear of hypoglycaemia and quality of life in children with Type 1 diabetes and their parents
Vainik et al. Personality‐obesity associations are driven by narrow traits: A meta‐analysis
Salom et al. Predictors of comorbid polysubstance use and mental health disorders in young adults—a latent class analysis
Tambon et al. Gabapentinoid abuse in France: evidence on health consequences and new points of vigilance
Hasin et al. Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients
Upton et al. Basic concepts in population modeling, simulation, and model‐based drug development: part 3—introduction to pharmacodynamic modeling methods
Lee et al. Impact of attention‐deficit/hyperactivity disorder comorbidity on longitudinal course in Internet gaming disorder: a 3‐year clinical cohort study
Conway et al. Transdiagnostic pathways from early social stress to psychopathology: a 20‐year prospective study
Taylor Epidemiology of refractory neuropathic pain
Bornovalova et al. Longitudinal twin study of borderline personality disorder traits and substance use in adolescence: developmental change, reciprocal effects, and genetic and environmental influences.
Hebebrand et al. Critical appraisal of the provisional DSM‐5 criteria for anorexia nervosa and an alternative proposal
Ray et al. Catching the alcohol buzz: an examination of the latent factor structure of subjective intoxication
Murray et al. Disagreeing about development: An analysis of parent‐teacher agreement in ADHD symptom trajectories across the elementary school years
Lovallo et al. Blunted stress reactivity reveals vulnerability to early life adversity in young adults with a family history of alcoholism
Mansour et al. Autonomous motivation: A predictor of treatment outcome in bulimia‐spectrum eating disorders
Marsot et al. High variability in the exposure of baclofen in alcohol‐dependent patients
Votaw et al. The Addictions Neuroclinical Assessment negative emotionality domain among treatment‐seekers with alcohol use disorder: Construct validity and measurement invariance
Harford et al. The dimensionality of DSM‐IV alcohol use disorders among adolescent and adult drinkers and symptom patterns by age, gender, and race/ethnicity
Beckwith et al. Increased delay discounting tracks with a high ethanol‐seeking phenotype and subsequent ethanol seeking but not consumption
Kim et al. Sociodemographic and clinical characteristics of old‐old suicide attempters compared with young‐old and middle‐aged attempters
Pohl et al. Circadian Genes Differentially Affect Tolerance to Ethanol in D rosophila
Waring et al. Evaluation of a QT nomogram for risk assessment after antidepressant overdose
Bright et al. Individual differences in the cortisol and salivary α‐amylase awakening responses in early childhood: Relations to age, sex, and sleep